Clinical Trial Update: Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing weekly TransCon hGH (ACP-001) to daily growth hormone injections in children with growth hormone deficiency, assessing safety, PK/PD, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somatropin (daily growth hormone) (somatropin)
• TransCon hGH (ACP-001)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Growth Hormone Deficiency (GHD) | Phase 2 | Status: COMPLETED | Results posted: 2017-01-19